Jacobs Levy Equity Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $477K | Sell |
|
|||||
|
2023
Q3 | $598K | Sell |
|
|||||
|
2023
Q2 | $1.5M | Sell |
|
|||||
|
2023
Q1 | $3.03M | Buy |
|
|||||
|
2022
Q4 | $3.38M | Buy |
|
|||||
|
2022
Q3 | $898K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5.37M | Sell |
|
|||||
|
2021
Q4 | $7.59M | Sell |
|
|||||
|
2021
Q3 | $9.63M | Buy |
|
|||||
|
2021
Q2 | $4.99M | Buy |
|
|||||
|
2021
Q1 | $6.7M | Buy |
|
|||||
|
2020
Q4 | $6.61M | Sell |
|
|||||
|
2020
Q3 | $3.64M | Buy |
|
|||||
|
2020
Q2 | $3.94M | Buy |
|
|||||
|
2020
Q1 | $1.7M | Buy |
|